Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
LEAMINGTON, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced significant updates to its Tilray Medical pricing programs in Canada, reinforcing its commitment to affordability, inclusivity, and patient support. These changes are designed to make medical cannabis more accessible for patients nationwide while recognizing the unique needs of seniors, first responders, pediatric patients, and those facing financial challenges.
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums).
That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
Tilray Brands (NASDAQ: TLRY) has once again found itself at the epicenter of market volatility, with its stock experiencing a significant dip this past week, closing near $1.34 USD as of early November 2025. This downturn comes amidst a complex tapestry of mixed signals, leaving investors and analysts grappling
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is bringing its celebrated craft beer brands to the heart of Asia. Tilray will debut select craft brands at the highly anticipated American Craft Beer Experience Festival in Japan, held November 22–24, 2025, in Tokyo’s vibrant Hibiya Park.
A new study suggests that states allowing medical cannabis sales through licensed dispensaries may see fewer prescriptions for strong opioids among cancer patients recovering from surgery. However, the same policy appears to coincide with a higher rate of hospital visits for reasons unrelated to cancer treatment.
A new study suggests that states allowing medical cannabis sales through licensed dispensaries may see fewer prescriptions for strong opioids among cancer patients recovering from surgery. However, the same policy appears to coincide with a higher rate of hospital visits for reasons unrelated to cancer treatment.
Food and beverage supplier MGP Ingredients (NASDAQ:MGPI)
will be announcing earnings results this Wednesday before market open. Here’s what to look for.
Coconut water company The Vita Coco Company (NASDAQ:COCO)
will be announcing earnings results this Wednesday before market hours. Here’s what to look for.
TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the global cannabis, beverage, and wellness industries, proudly celebrates the seventh anniversary of cannabis legalization in Canada. As the largest federally legal cannabis market in the world, Canada’s progressive regulatory framework has fostered innovation and created vast economic opportunities for Canadian businesses and communities and set the global benchmark for responsible cannabis legalization and industry development.
Tilray’s third quarter results were met with a strong positive response from the market, reflecting the company's progress in expanding its diversified business model and achieving a notable improvement in operating margin. Management attributed the quarter’s performance to double-digit growth in Canadian adult-use and international cannabis segments, as well as operational improvements across its beverage and wellness divisions. CEO Irwin Simon highlighted that, outside of a flat beverage segment affected by SKU rationalization, all core business lines contributed to revenue growth, with focused efforts on product innovation and efficiency driving the company’s improved profitability.
A Marijuana Moment report cites findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions.
Target is testing the sale of THC-infused drinks at a small number of stores in Minnesota, according to executives from cannabis drink companies involved in the rollout.
Target is testing the sale of THC-infused drinks at a small number of stores in Minnesota, according to executives from cannabis drink companies involved in the rollout.
NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, has announced plans to expand its medical cannabis operations into Panama. In connection with its expansion into Panama, Tilray has entered into a joint venture with Top Tech Global Inc. (“Top Tech”), whose members have extensive experience in the distribution of medical devices since 2014. Together, Tilray and Top Tech, through their joint venture company, Solana Life Group, have received a medical cannabis license issued by the National Directorate of Pharmacy and Drugs in Panama authorizing the cultivation, manufacturing, import, export, distribution and sale of medical cannabis in Panama.
